Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Photoreceptors and Plant Responses to Light02:00

Photoreceptors and Plant Responses to Light

Light plays a significant role in regulating the growth and development of plants. In addition to providing energy for photosynthesis, light provides other important cues to regulate a range of developmental and physiological responses in plants.
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing Quality of Colorectal Cancer Care at Commission on Cancer Accredited Hospitals.

Journal of the American College of Surgeons·2026
Same author

Developing Specialty-Specific Workplace Standards for Surgeons: A Framework to Support Sustainable Surgical Careers.

Journal of the American College of Surgeons·2026
Same author

Implications of Eliminating Medicare's Inpatient Only List.

JAMA surgery·2026
Same author

Ensuring Quality Surgical Care in the 21st Century.

Annals of surgery·2025
Same author

MACULAR EXUDATION ASSOCIATED WITH A RACEMOSE HEMANGIOMA, VASOPROLIFERATIVE TUMOR, AND COATS-LIKE VASCULOPATHY.

Retinal cases & brief reports·2025
Same author

Reply to Comment on: Dropped Lens Fragments Retrieval Using Endoscopy-Assisted Pars Plana Vitrectomy in Patients With Corneal Opacity.

American journal of ophthalmology·2025

Related Experiment Video

Updated: Jun 19, 2026

Scanning Light Scattering Profiler (SLPS) Based Methodology to Quantitatively Evaluate Forward and Backward Light Scattering from Intraocular Lenses
06:55

Scanning Light Scattering Profiler (SLPS) Based Methodology to Quantitatively Evaluate Forward and Backward Light Scattering from Intraocular Lenses

Published on: June 6, 2017

Blue-blocking IOLs decrease photoreception without providing significant photoprotection.

Martin A Mainster1, Patricia L Turner

  • 1Department of Ophthalmology, University of Kansas School of Medicine, Prairie Village, Kansas, USA. mmainste@kumc.edu

Survey of Ophthalmology
|November 4, 2009
PubMed
Summary
This summary is machine-generated.

Blue-blocking intraocular lenses (IOLs) with yellow chromophores reduce essential blue light, impairing vision and circadian rhythms without proven benefits for age-related macular degeneration (AMD). Their use is not evidence-based, restricting photoreception unnecessarily.

More Related Videos

A Novel Light Damage Paradigm for Use in Retinal Regeneration Studies in Adult Zebrafish
09:31

A Novel Light Damage Paradigm for Use in Retinal Regeneration Studies in Adult Zebrafish

Published on: October 24, 2013

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

Related Experiment Videos

Last Updated: Jun 19, 2026

Scanning Light Scattering Profiler (SLPS) Based Methodology to Quantitatively Evaluate Forward and Backward Light Scattering from Intraocular Lenses
06:55

Scanning Light Scattering Profiler (SLPS) Based Methodology to Quantitatively Evaluate Forward and Backward Light Scattering from Intraocular Lenses

Published on: June 6, 2017

A Novel Light Damage Paradigm for Use in Retinal Regeneration Studies in Adult Zebrafish
09:31

A Novel Light Damage Paradigm for Use in Retinal Regeneration Studies in Adult Zebrafish

Published on: October 24, 2013

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

Area of Science:

  • Ophthalmology
  • Photobiology
  • Vision Science

Background:

  • Violet and blue light are crucial for various photoreceptor functions, including scotopic, melanopsin, and S-cone vision, as well as circadian regulation (melatonin suppression).
  • Blue-blocking intraocular lenses (IOLs) contain yellow chromophores that filter out significant portions of blue and violet light (400-500 nm).

Purpose of the Study:

  • To evaluate the impact of yellow chromophores in blue-blocking IOLs on visual function and circadian photoreception.
  • To assess the clinical evidence supporting the use of blue-blocking IOLs for preventing age-related macular degeneration (AMD).

Main Methods:

  • Analysis of the spectral transmission properties of blue-blocking IOLs.
  • Review of existing epidemiological and clinical evidence regarding IOLs, light exposure, and AMD.
  • Comparison of photoreception in pseudophakic eyes with and without yellow chromophore IOLs.

Main Results:

  • Yellow chromophores in IOLs significantly reduce short-wavelength light, adversely affecting photopic luminance contrast, S-cone sensitivity, mesopic acuity, and circadian photoreception.
  • Blue-blocking IOLs offer no demonstrable clinical benefits in reducing disability glare or improving contrast sensitivity.
  • Epidemiological data do not support environmental light exposure or cataract surgery as significant risk factors for AMD progression.

Conclusions:

  • The use of blue-blocking IOLs is not supported by evidence-based medicine, as they provide no proven benefits for AMD prevention while causing significant photoreception deficits.
  • Yellow chromophores in IOLs act as ineffective placebos for AMD prevention, permanently limiting crucial dim light and circadian photoreception.
  • Colorless UV-blocking IOLs offer superior dim light and circadian photoreception compared to blue-blocking IOLs, representing a more age-appropriate standard of care.